Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NEVRO CORP | 85,967 | reported | 28 May 2023 | tx 42+191,143−39,601 |
| Acutus Medical, Inc. | 19,600 | reported | 15 Jun 2023 | tx 6+75,363 |
| THORATEC CORP | 0 | reported | 08 Oct 2015 | tx 6+126,555−126,555 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Jun 2023 | GRANT_AWARD | Acutus Medical, Inc. | 8,400 | 0.00 USD | |
| 15 Jun 2023 | GRANT_AWARD | Acutus Medical, Inc. | 19,600 | 0.00 USD | deriv |
| 28 May 2023 | TAX_WITHHOLDING | NEVRO CORP | 1,143 | 26.45 USD | |
| 07 Mar 2023 | GRANT_AWARD | NEVRO CORP | 39,282 | 0.00 USD | |
| 02 Mar 2023 | TAX_WITHHOLDING | NEVRO CORP | 1,979 | 33.99 USD | |
| 28 Feb 2023 | TAX_WITHHOLDING | NEVRO CORP | 4,718 | 31.44 USD | |
| 06 Aug 2022 | TAX_WITHHOLDING | NEVRO CORP | 4,365 | 47.11 USD | |
| 16 Jun 2022 | GRANT_AWARD | Acutus Medical, Inc. | 8,400 | 0.00 USD | |
| 16 Jun 2022 | GRANT_AWARD | Acutus Medical, Inc. | 19,600 | 0.00 USD | deriv |
| 02 Mar 2022 | TAX_WITHHOLDING | NEVRO CORP | 2,031 | 71.27 USD | |
| 28 Feb 2022 | GRANT_AWARD | NEVRO CORP | 26,069 | 0.00 USD | |
| 10 Aug 2021 | GRANT_AWARD | Acutus Medical, Inc. | 4,172 | 0.00 USD | |
| 10 Aug 2021 | GRANT_AWARD | Acutus Medical, Inc. | 15,191 | 0.00 USD | deriv |
| 06 Aug 2021 | TAX_WITHHOLDING | NEVRO CORP | 4,366 | 119.73 USD | |
| 10 Mar 2021 | SALE | NEVRO CORP | 750 | 148.08 USD | |
| 10 Mar 2021 | EXERCISE | NEVRO CORP | 750 | 64.95 USD | |
| 10 Mar 2021 | EXERCISE | NEVRO CORP | 750 | 0.00 USD | deriv |
| 02 Mar 2021 | GRANT_AWARD | NEVRO CORP | 9,596 | 0.00 USD | |
| 02 Mar 2021 | TAX_WITHHOLDING | NEVRO CORP | 706 | 168.11 USD | |
| 10 Feb 2021 | EXERCISE | NEVRO CORP | 750 | 64.95 USD | |
| 10 Feb 2021 | SALE | NEVRO CORP | 750 | 182.55 USD | |
| 10 Feb 2021 | EXERCISE | NEVRO CORP | 750 | 0.00 USD | deriv |
| 11 Jan 2021 | EXERCISE | NEVRO CORP | 750 | 64.95 USD | |
| 11 Jan 2021 | SALE | NEVRO CORP | 750 | 169.80 USD | |
| 11 Jan 2021 | EXERCISE | NEVRO CORP | 750 | 0.00 USD | deriv |